tradmap

SBC SBC Medical Group Holdings Inc

$5.31 +0.66%

Data as of close

Healthcare · Services-Offices & Clinics Of Doctors Of Medicine

SBC Medical Group Holdings Inc (SBC) is a healthcare company in the Services-Offices & Clinics Of Doctors Of Medicine industry, with a market capitalization of $546 million. Shares last traded at $5.31, 7.7% below their 52-week high. Over the past year the stock is up 57.1%. SBC trades at a price-to-earnings ratio of 11.14, below the Services-Offices & Clinics Of Doctors Of Medicine median of 91.04. Net profit margin is 28.0%, above the peer median of -6.2%. Revenue declined 15.5% year over year.

Market Cap
$546M
Shares Out
102.8M
EPS (TTM)
$0.48
P/E (TTM)*
11.14
P/S Ratio
3.12
P/B Ratio
2.07
Dividend / Share
—
Dividend Yield
—
52-Week High
$5.75
52-Week Low
$2.79
Volume (venue)
11,523
Avg Vol (3m, venue)
8,448.571

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-1.03%
1M
+4.32%
3M
+67.77%
6M
+62.39%
YTD
+23.34%
1Y
+57.10%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
52.61
SMA (50)
$4.89
SMA (200)
$3.91
Price vs SMA50
+8.64%
Price vs SMA200
+35.70%
ATR (14)
$0.26

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$175M
Net Income
$49M
Gross Margin
71.9%
Operating Margin
37.3%
Net Margin
28.0%
Return on Equity
18.6%
Return on Assets
12.1%
Current Ratio
3.31
Debt / Equity
0.14
Revenue Growth (YoY)
-15.5%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.10 2026-08-13
Q1 2026 $0.11 2026-05-14
Q4 2025 (derived) $0.15 2026-03-27
FY 2025 $0.50 2026-03-27
Q3 2025 $0.12 2025-11-14
Q2 2025 $0.02 2025-08-13

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Offices & Clinics Of Doctors Of Medicine peers

SBC vs 11 industry peers (Services-Offices & Clinics Of Doctors Of Medicine), by market cap. Data as of close

P/E vs peers
11.14 / 91.04 med
-88% discount
P/S vs peers
3.12 / 0.94 med
+231% premium
Net margin vs peers
28.0% / -6.2% med
above median
1–11 of 11
HIMSHims & Hers Health, Inc.$5.9B—2.28-5.5%-8.85%
TDOCTeladoc Health, Inc.$1.6B—0.64-6.3%+1.41%
STLNStarling Oncology, Inc.$637M—1.08-6.2%-4.21%
SBCSBC Medical Group Holdings Inc$546M11.143.1228.0%+0.66%
AIRSAirsculpt Technologies, Inc.$120M—0.80-7.8%-5.11%
LFMDLifemd, Inc.$111M551.520.670.1%+0.00%
WSTNWestin Acquisition Corp$81M91.04——+0.00%
BMGLBasel Medical Group Ltd$8M———+1.48%
CCMConcord Medical Services Holdings Ltd———-20.2%+4.94%
AUNAAuna S.A.————-0.22%
SBCWWSBC Medical Group Holdings Inc————+31.31%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.